Our vaccine is up to 90% effective, German and American company
A German company and its American partner company have claimed that their joint vaccine has proved to be 90% effective in preventing corona infection.
German company BioNTech and its US partner Pfizer have said that the results of the third phase of their corona vaccine are very encouraging and that the vaccine has proved to be 90% effective in preventing corona infection. ۔
The statement, issued by the two companies, was based on the success of a large-scale trial of the corona vaccine they developed. According to their reports, the vaccine did not cause any significant side effects or concerns. Researchers hope that after this vaccine, the protection against corona will not be limited.
If their claim proves true, the Pfizer and Biotech vaccine will be a significant step in the fight against the corona epidemic. "We should be more optimistic that the vaccine will have a protective effect for a year," Ogor Sahn, chief executive officer of the German company Biotech, told Reuters.
According to a statement issued by Albert Borla, Chairman and CEO of Pfizer, "Preliminary results from the third phase of the COD vaccine provide evidence that our vaccine protects against COD 19."
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
— Pfizer Inc. (@pfizer) November 9, 2020
It is expected to produce 50 million meals this year
Medical testing of the third phase of the vaccine began in late July this year and involved 43,500 people. Both companies say they will submit a formal application to the US Food and Drug Administration next week for permission to use the vaccine.
Biotech and Pfizer have already won a 1.95 billion deal to supply the United States with 100 doses of their vaccine. These companies also have agreements with the European Union, the United Kingdom, Canada and Japan. Preparations for this vaccine have already begun to save time. He hopes to produce 50 million doses by 2020 alone, which will be enough to vaccinate 25 million people.